|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.028 +0.001 (+3.704%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | -8.258% | 1.088% | -14.183% | 0.273% | -5.391% |
| ROAE (%) | -10.043% | 1.528% | -21.702% | 0.366% | -6.209% |
| Return on Capital Employed (%) | -10.692% | 1.486% | -24.833% | 0.333% | -5.971% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 44.162% | 43.615% | 43.115% | 46.471% | 48.943% |
| EBITDA Margin (%) | -18.366% | 13.195% | -70.458% | 21.685% | -11.160% |
| Pre-tax Profit Margin (%) | -26.263% | 3.253% | -89.276% | 5.344% | -22.563% |
| Net Profit Margin (%) | -25.008% | 4.018% | -64.396% | 1.125% | -21.594% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 3.714 X | 3.471 X | 1.757 X | 2.198 X | 3.582 X |
| Quick Ratio (X) | 3.554 X | 3.332 X | 1.688 X | 2.136 X | 3.509 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 17.601% | 18.726% | 38.652% | 29.700% | 14.526% |
| Total Debt / Total Assets (%) | 2.057% | 2.975% | 4.152% | 3.323% | 3.067% |
| Net Debt / Total Assets (%) | -26.847% | -25.795% | -18.444% | -23.368% | -20.245% |
| Total Debt / Shareholders' Funds (%) | 2.470% | 3.658% | 6.567% | 4.958% | 3.650% |
| Long Term Debt / Shareholders' Funds (%) | 1.494% | 2.069% | 5.122% | 3.921% | 2.704% |
| Net Debt / Shareholders' Funds (%) | -32.230% | -31.723% | -29.172% | -34.861% | -24.094% |
| Net Cash / (Debt) ($) | 138.960M | 156.079M | 141.578M | 226.983M | 153.364M |
| Net Cash / (Debt) per share ($) | 0.028 | 0.031 | 0.028 | 0.045 | 0.030 |
| Total Debt / Capital Employed (%) | 2.456% | 3.581% | 6.418% | 4.551% | 3.496% |
| Interest Coverage Ratio (X) | N/A | 2.647 X | N/A | 2.369 X | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 48.697 Day | 57.507 Day | 58.603 Day | 37.275 Day | 26.406 Day |
| Receivables Turnover (Day) | 208.825 Day | 178.354 Day | 141.018 Day | 135.365 Day | 151.544 Day |
| Payables Turnover (Day) | 31.827 Day | 71.991 Day | 87.794 Day | 43.974 Day | 10.552 Day |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -46,355,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.009 |
| NBV Per Share ($) | HKD 0.086 |